# IRulya Therapeutics (IRLA) — Analyst Forecast

IRLA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/irla/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 8 | 0 | 0 | 8 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $70.00 | $74.20 | $82.00 | 5 |

Last price $28.71 (as of Oct 12, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 9, 2026 | Raymond James | Initiated Coverage | Outperform | $72.00 |
| Sep 24, 2026 | Rodman & Renshaw | Initiated Coverage | Buy | $70.00 |
| Sep 22, 2026 | Citizens | Upgraded | Market Perform → Market Outperform | $77.00 |
| Aug 18, 2026 | Cantor Fitzgerald | Maintained | Overweight | $70.00 |
| Jul 29, 2026 | Oppenheimer | Initiated Coverage | Outperform | $82.00 |
| Jun 24, 2026 | Leerink Partners | Initiated Coverage | Outperform | $4.00 |
| Jun 23, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | $4.00 |
| Jan 30, 2026 | D. Boral Capital | Downgraded | Buy → Hold | — |
| Jan 30, 2026 | Citizens | Downgraded | Market Outperform → Market Perform | — |
| Jan 29, 2026 | D. Boral Capital | Maintained | Buy | $5.00 |
| Dec 15, 2025 | D. Boral Capital | Maintained | Buy | $5.00 |
| Nov 13, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Sep 26, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Aug 15, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Aug 12, 2025 | JMP Securities | Maintained | Market Outperform | $8.00 |
| Aug 5, 2025 | JMP Securities | Initiated Coverage | Market Outperform | $9.00 |
| Jul 17, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Jun 13, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Jun 4, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |
| Mar 25, 2025 | D. Boral Capital | Maintained | Buy | $4.00 |

## Frequently Asked Questions

### What is the price target for IRLA stock?

The average 12-month analyst price target for IRulya Therapeutics (IRLA) is $74.20, with a high estimate of $82.00 and a low of $70.00, across 5 analysts.

### Is IRLA a buy, sell, or hold?

Analysts covering IRulya Therapeutics currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for IRLA?

The average price target of $74.20 implies 158.45% upside from the last price of $28.71.

### What is the latest analyst rating on IRLA?

On Oct 9, 2026, Raymond James initiated coverage of IRulya Therapeutics at Outperform with a price target of $72.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).